Tempest Therapeutics Inc. (TPST) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Tempest Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$0.54
+5.72% today
Market cap
$10M
Overall quality
—
Kronos AI 30-day
—
Tempest Therapeutics Inc. (TPST) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $10M. It trades at $0.54, up 5.72% today. 1 analysts' average target of $7.00 implies +1196.3% from today's price.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $7.00 |
| Low – high | $7.00 – $7.00 |
| Analysts | 1 |
| Upside to average | +1196.3% |
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.